Acasă › Cancer de sân › Colorado › Denver
Studii clinice pentru Cancer de sân în Denver, CO
29 studii pentru Cancer de sân caută participanți în și în jurul orașului Denver (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
The Vanguard Study: Testing a New Way to Screen for Cancer
În curs de recrutareVoluntari sănătoși bineveniți
- Kaiser Permanente-Franklin, Denver
A Study of PHST001 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Sarah Cannon Research Institute (SCRI) Oncology Partners - Denver Health One, Denver
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- Rocky Mountain Cancer Center, Denver
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
În curs de recrutareFaza 3
- Rocky Mountain Cancer Centers, Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- AdventHealth Porter, Denver
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
În curs de recrutareFaza 2
- Rocky Mountain Cancer Centers, Denver
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
În curs de recrutareFaza 1
- Sarah Cannon Research Institute (Scri) At Health One, Denver
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
În curs de recrutareFaza 3
- UCHealth Cherry Creek Medical Center ( Site 0094), Denver
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
În curs de recrutareFaza 3
- Research Site, Denver
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
În curs de recrutareFaza 3
- UCHealth Cherry Creek Medical Center, Denver
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
În curs de recrutareFaza 2
- Saint Joseph Hospital - Cancer Centers of Colorado, Denver
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
În curs de recrutareFaza 3
- Intermountain Health Cancer Center Saint Joseph ( Site 0062), Denver
- Rocky Mountain Cancer Centers (RMCC) ( Site 8006), Denver
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
În curs de recrutareFaza 3
- Clinical Trial Site, Denver
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
În curs de recrutareFaza 3
- St. Joseph Hospital-Cancer Centers of Colorado, Denver
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Skin Cancer Institute, Englewood · La 6 mi distanță
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
În curs de recrutareFaza 3
- UCHealth - Cherry Creek, Denver
- Saint Joseph Hospital - Cancer Centers of Colorado, Denver
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1
- Sarah Cannon Research Institute at HealthONE, Denver
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
În curs de recrutareFaza 1
- Sarah Cannon Research Institute - Denver DDU, Denver
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1
- Sarah Cannon Research Institute (SCRI) at HealthONE-Denver, Denver
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
În curs de recrutareFaza 2/3
- Rocky Mountain Cancer Centers, Denver
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
În curs de recrutareFaza 3
- Rocky Mountain Cancer Centers, Denver
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Sarah Cannon Research Institute, Denver
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
În curs de recrutareFaza 3
- Rocky Mountain Cancer Centers LLP, Denver
- Rocky Mountain Cancer Centers LLP, Englewood · La 6 mi distanță
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
În curs de recrutareFaza 3
- UCHealth - Cherry Creek, Denver
- Rose Medical Center, Denver
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- Kaiser Permanente-Franklin, Denver
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Centers-Midtown, Denver
- și încă 1
The Immune System's Response to Young Women's Breast Cancer
În curs de recrutareStudiu observațional
- Denver Health Hospital Authority, Denver
- UCHealth Cherry Creek Medcial Center, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Denver
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
În curs de recrutareFaza 1
- HealthONE, Denver
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
În curs de recrutareStudiu observațional
- Comprehensive Breast Care of Denver, Denver
Studii pentru Cancer de sân în alte orașe
- New York City, NY136 studii
- Houston, TX126 studii
- Boston, MA112 studii
- Nashville, TN81 studii
- Los Angeles, CA73 studii
- Edison, NJ68 studii
- St. Louis, MO64 studii
- Queens, NY64 studii
- Durham, NC64 studii
- Chicago, IL59 studii
- Philadelphia, PA56 studii
- Dallas, TX55 studii
Alte studii în Denver
- Cancer metastatic29 studii
- Cancer pulmonar cu celule non-pătrate27 studii
- Mielom multiplu27 studii
- Cancer colorectal23 studii
- Melanom19 studii
- Cancer de prostată19 studii
- Cancer (toate tipurile)18 studii
- Cancer ovarian16 studii
- Cancer pulmonar16 studii
- Cancer endometrial15 studii
- Limfom non-Hodgkin14 studii
- Cancer pancreatic13 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.